Stock PURE PURE BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases PURE Bioscience, Inc.

Equities

PURE

US74621T2096

Market Closed - OTC Markets
Other stock markets
 12:24:58 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.071 USD +1.43% Intraday chart for PURE Bioscience, Inc. +5.97% -45.26%
Mar. 22 PURE Bioscience, Inc. announced that it has received $3 million in funding CI
Mar. 18 PURE Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results
BU
PURE Bioscience Reports Fiscal First Quarter 2024 Financial Results
BU
PURE Bioscience Reports Fiscal 2023 Financial Results
BU
PURE Bioscience to unveil “PURE Genius” Food Safety Program at the Annual International Association for Food Protection Meeting
BU
PURE Bioscience Reports Fiscal 2023 Third Quarter And Nine-Month Financial Results
BU
PURE BIOSCIENCE, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results
AQ
PURE BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results
BU
PURE BIOSCIENCE, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
PURE BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
PURE Bioscience Reports Fiscal First Quarter 2023 Financial Results
BU
PURE BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AQ
PURE Bioscience Reports Fiscal 2022 Financial Results
BU
PURE BIOSCIENCE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
AQ
PURE Bioscience : Reports Fiscal 2022 Third Quarter And Nine-Month Financial Results - Form 8-K
PU
PURE BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
PURE Bioscience Reports Fiscal 2022 Third Quarter and Nine-Month Financial Results
BU
PURE BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
PURE Bioscience : Reports Fiscal 2022 Second Quarter And Six-Month Financial Results - Form 8-K
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PURE Stock
  4. News PURE Bioscience, Inc.
  5. Press Releases